| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4029057 | Ophthalmology | 2008 | 8 Pages |
Abstract
We developed a technique of direct ophthalmic artery infusion of melphalan for children with retinoblastoma. The technique had minimal systemic side effects (one patient had grade 3 neutropenia) and minimal local toxicity. Among the first 9 cases treated with this technique, 7 eyes destined to be enucleated were salvaged.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
David H. MD, Ira J. MD, Scott E. MD, PhD, Jonathan W. MD, Y. Pierre MD,